NasdaqCM - Nasdaq Real Time Price USD

Oncternal Therapeutics, Inc. (ONCT)

9.41 -0.07 (-0.74%)
At close: May 28 at 4:00 PM EDT
8.98 -0.43 (-4.57%)
After hours: May 28 at 4:49 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Expense
38,350.00
41,714.00
44,947.00
31,366.00
17,542.00
--
Operating Income
-38,350.00
-41,714.00
-44,947.00
-31,366.00
-17,542.00
--
Net Non Operating Interest Income Expense
1,970.00
2,235.00
777.00
33.00
16.00
--
Other Income Expense
--
--
--
--
301.00
-19,356.00
Pretax Income
-36,380.00
-39,479.00
-44,170.00
-31,333.00
-17,225.00
--
Net Income Common Stockholders
-36,380.00
-39,479.00
-44,170.00
-31,333.00
-17,225.00
--
Diluted NI Available to Com Stockholders
-36,380.00
-39,479.00
-44,170.00
-31,333.00
-17,225.00
--
Basic EPS
-12.33
-13.43
-16.80
-12.80
-17.00
--
Diluted EPS
-12.33
-13.43
-16.80
-12.80
-17.00
--
Basic Average Shares
2,948.25
2,940.00
2,630.00
2,466.05
1,015.25
--
Diluted Average Shares
2,948.25
2,940.00
2,630.00
2,466.05
1,015.25
--
Total Operating Income as Reported
-38,350.00
-41,714.00
-44,947.00
-31,366.00
-17,542.00
--
Total Expenses
38,350.00
41,714.00
44,947.00
31,366.00
17,542.00
--
Net Income from Continuing & Discontinued Operation
-36,380.00
-39,479.00
-44,170.00
-31,333.00
-17,225.00
--
Normalized Income
-36,380.00
-39,479.00
-44,170.00
-31,333.00
-17,225.00
--
Interest Income
1,970.00
2,235.00
777.00
33.00
16.00
--
Net Interest Income
1,970.00
2,235.00
777.00
33.00
16.00
--
EBIT
-38,350.00
-41,714.00
-44,947.00
-31,366.00
-17,542.00
--
EBITDA
-38,350.00
-41,714.00
-44,947.00
-31,366.00
-17,542.00
--
Net Income from Continuing Operation Net Minority Interest
-36,380.00
-39,479.00
-44,170.00
-31,333.00
-17,225.00
--
Total Unusual Items Excluding Goodwill
--
--
--
--
--
-19,356.00
Total Unusual Items
--
--
--
--
--
-19,356.00
Normalized EBITDA
-38,350.00
-41,714.00
-44,947.00
-31,366.00
-17,542.00
--
12/31/2019 - 2/3/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LPTX Leap Therapeutics, Inc.
2.2800
-4.20%
 
APTO Aptose Biosciences Inc.
1.1442
+3.08%
 
BCAB BioAtla, Inc.
1.6800
-1.75%
 
CRVS Corvus Pharmaceuticals, Inc.
2.0200
-1.94%
 
CRIS Curis, Inc.
11.17
-0.27%
 
ENTA Enanta Pharmaceuticals, Inc.
11.93
-0.83%
 
AVBP ArriVent BioPharma, Inc.
18.97
-1.40%
 
ALLK Allakos Inc.
1.3900
-2.11%
 
PDSB PDS Biotechnology Corporation
3.1100
+0.97%
 
VINC Vincerx Pharma, Inc.
0.6590
-3.63%